Status:
UNKNOWN
Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis
Lead Sponsor:
Hospital Provincial de Castellon
Conditions:
COVID
Pneumonia, Viral
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The administration of low-dose lung irradiation produces anti-inflammatory effects that will decrease the pulmonary inflammatory response. The present study will evaluate the efficacy of treatment wi...
Detailed Description
The WHO has officially confirmed that: "Currently, there is no specific pharmacological available treatment for COVID-19". Beyond vital support, there are not currently treatment options for Coronavi...
Eligibility Criteria
Inclusion
- Patients over 65 years old
- Hospitalized with COVID-19 positive not subsidiary of ICU with severe disease defined by the presence of ALL the following characteristics:
- Presence of unilateral or bilateral pulmonary infiltrates in chest X-ray or computed tomography (CT).
- Acute respiratory failure expressed by PaO2 / FIO2 \<300.
- Lymphopenia ≤0.8 × 109 / L (800 lymphocytes / ml).
- Patients with ≤8 days from the onset of symptoms.
Exclusion
- Patient not consent to participate
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04414293
Start Date
October 1 2020
End Date
December 31 2021
Last Update
February 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Provincial de Castellon
Castellon, Castellon, Spain, 12002